What is CBG Biotech?
CBG Biotech specializes in advanced random number generation (RNG) solutions, providing critical tools for statistical analysis, gaming, and cryptographic processes. The company's offerings are designed to deliver reliable and efficient randomization techniques, catering to a diverse clientele across various industries that require robust randomization capabilities. Their focus on innovation aims to address the evolving needs for high-quality RNG in complex applications.
How much funding has CBG Biotech raised?
CBG Biotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CBG Biotech?
With a substantial late-stage funding context, CBG Biotech is poised for significant scaling and market penetration. The recent strategic investment suggests a focus on expanding its technological infrastructure, enhancing its product suite, and potentially exploring new market verticals. Future developments are likely to center on solidifying its leadership in the RNG solutions space and capitalizing on the growing demand for secure and statistically sound randomization in digital environments.
See full CBG Biotech company page
